Canada: BYOOVIZ Is Confusing With BEOVU: Federal Court Finds Violation Of Novartis' Trademark Rights - Smart & Biggar

In a decision dated January 24, 2024, Justice Pallotta allowed Novartis' application, finding that Biogen and Samsung's use of the trademark BYOOVIZ in association with an ophthalmologic drug...